A detailed history of Coppell Advisory Solutions Corp. transactions in Abbott Laboratories stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 19,335 shares of ABT stock, worth $2.25 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
19,335
Previous 13,244 45.99%
Holding current value
$2.25 Million
Previous $1.31 Billion 67.48%
% of portfolio
0.41%
Previous 0.43%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $667,086 - $736,767
6,091 Added 45.99%
19,335 $2.2 Billion
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $1.09 Million - $1.29 Million
-11,294 Reduced 46.03%
13,244 $1.31 Billion
Q4 2022

Feb 17, 2023

BUY
$95.06 - $111.52 $2.33 Million - $2.74 Million
24,538 New
24,538 $2.69 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Coppell Advisory Solutions Corp. Portfolio

Follow Coppell Advisory Solutions Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.